Patent ID: 7538101

Claim:
A compound of formula I, wherein: R 1 is selected from the group consisting of hydrogen, lower alkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower halogenoalkyl, lower cycloalkylalkyl, lower alkanoyl, lower alkoxycarbonyl, lower cyanoalkyl, lower alkylsulfonyl, phenylsulfonyl wherein the phenyl ring may be unsubstituted or substituted with one or two groups independently selected from lower alkyl, halogen, cyano, lower halogenoalkyl, lower alkoxy, lower halogenoalkoxy and lower hydroxyalkyl; phenyl unsubstituted or substituted with one or two groups independently selected from lower alkyl, halogen, cyano, lower halogenoalkyl, lower alkoxy, lower halogenoalkoxy and lower hydroxyalkyl; lower phenylalkyl, wherein the phenyl ring may be unsubstituted or substituted with one or two groups independently selected from lower alkyl, halogen, cyano, lower halogenoalkyl, lower alkoxy, lower halogenoalkoxy and lower hydroxyalkyl; and heteroaryl unsubstituted or substituted with one or two groups independently selected from lower alkyl, lower alkoxy, halogen, lower halogenoalkyl, lower halogenoalkoxy and cyano; R 2 is hydrogen or halogen; G is a group selected from wherein m is 0, 1 or 2; R 3 is selected from lower alkyl, lower halogenoalkyl, cycloalkyl, halogenocycloalkyl, lower cycloalkylalkyl and lower phenylalkyl; n is 0, 1 or 2; R 4 is lower alkyl; p is 0, 1 or 2; q is 0, 1 or 2; A is selected from CR 10 R 10′ , O and S; R 5 , R 5′ ,R 6 , R 6′ , R 7 , R 7′ , R 10 and R 10′ independently from each other are selected from the group consisting of hydrogen, lower alkyl, hydoxy, halogen and dialkylamino, or R 6 and R 10 together form a double bond; R 8 is lower alkyl; R 9 is C 3 -C 6 -alkyl; and pharmaceutically acceptable salts thereof.